Posts by John

Theriva Biologics gains Spanish approval for Phase 2a trials of VCN-01. Learn how this novel oncolytic virus targets treatment-resistant pancreatic cancer.

The FDA has granted Priority Review to Agios Pharmaceuticals’ mitapivat for Sickle Cell Disease. Learn how this PK activator could transform SCD treatment.

The FDA has greenlit a single Phase 3 trial for ATH434, potentially accelerating the approval process for a new Multiple System Atrophy treatment.

The EMA has fast-tracked the review of daraxonrasib for metastatic pancreatic cancer, potentially offering new hope for treatment-resistant patients.

Vertex Pharmaceuticals faces mounting pressure to integrate its $10B expansion strategy. Explore the impact on R&D, clinical trials, and biotech innovation.

A new oral weight loss pill has outperformed Ozempic in recent clinical trials. Discover the impact of this promising discovery on obesity treatment.

Discover how a new five-agent AI system is revolutionizing clinical trial design by rapidly analyzing real-world patient records to accelerate research.

A new nerve-repairing peptide therapy shows promising results in clinical trials, offering hope for functional recovery in spinal cord injury patients.

Researchers have launched a clinical trial testing new treatments for a challenging Ebola strain. Discover the impact on outbreak preparedness and care.

Discover how AI is revolutionizing oncology by enhancing surgical precision, accelerating drug discovery, and optimizing clinical trial designs for patients.